SWOT Analysis for Regenxbio Inc

MACD Crossover Above Signal Line
Positive Breakout First Resistance ( LTP > R1)
Significant (over 30%) distance from 52 week high
Rising Net Cash Flow and Cash from Operating activity
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
MACD crossed above signal line previous end of day
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Positive Breakout (LTP > R1)
Top Gainers
Stock with Low PE (PE < = 10)
Biggest Price Gainers from Open

Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low DVM Stocks - Stocks to Exercise Caution On
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Risky Value (DVM)
Low durability companies
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Stocks Underperforming their Industry Price Change in the Quarter